- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05261256
Cardiac Impairments Following Pediatric Cardiotoxic Anti-cancer Treatment
Early Detection of Cardiac Impairments Following Cardiotoxic Anti-cancer Treatment During Childhood and Adolescence - A Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cardiovascular late effects following treatment for pediatric cancer are problematic. Early detection of subclinical changes is hardly possible using conventional diagnostic methods, but seems to be feasible during physical strain (exercise stress echocardiography).
This feasibility study examines as main objective the recruitment strategy and investigation method in 10-25-year olds in the first and fifth year after the end of acute anti-cancer therapy (n=40 participants with a history of childhood cancer and n=40 control subjects). The heart function is examined by means of exercise stress echocardiography and spiroergometry in comparison with healthy age- and gender-matched control subjects.
Secondary aims are the evaluation of aditional echocardiography markers and levels of physical activity.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Munich, Germany, 80992
- Institute of Preventive Pediatrics, Department of Sport and Health Sciences, Technical University of Munich, Germany
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Participants with a history of pediatric cancer will be recruited during appointments in follow-up care at two departments for pediatric cancer in Munich.
Healthy peers will be recruited within social environment of participants with a history of cancer (siblings, close friends) and within schools and sport clubs.
Description
Inclusion criteria for all participants:
- Aged between 10 and 25 years
- Body height of ≥1,40m (required for performing the examination on the semi supine bicycle ergometer)
- Signed informed assent (minor participant) and consent (legal guardian and full-aged participant)
Additional inclusion criteria for participants following cancer treatment:
- Completion of acute cancer treatment with anthracyclines and/or chest radiation
- End of treatment 12 months and five years ago (± three months)
- Medical approval for study participation
Additional inclusion criteria for healthy control subjects:
- Appropriate as matched pair with respect to age and gender
Exclusion Criteria:
- Known cardiovascular diseases (incoherent with cardiotoxic treatment)
- Inability to follow study instructions (e.g., mental retardation, language)
- Acute orthopedic injury (e.g., bone fracture) or orthopedic impairments that preclude examination on a bicycle ergometer (e.g., instable prosthetic device)
All participants receive a basic physical and cardiological examination at rest as part of the study protocol to ensure capability before performing the exercise stress echocardiography.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Participants treated for pediatric cancer
This group includes children, adolescents and young adults treated for pediatric cancer who received anthracyclines and/or chest radiation during treatment.
|
Study participants perform an exercise stress echocardiography on a semi-supine bicycle ergometer using using a continuous incremental bicycle protocol with a work rate increment every 3 minutes according to gender and weight.
|
|
Healthy control subjects
This group includes healthy children, adolescents and young adults without a history of pediatric cancer as age-and gender-matched control subjects.
|
Study participants perform an exercise stress echocardiography on a semi-supine bicycle ergometer using using a continuous incremental bicycle protocol with a work rate increment every 3 minutes according to gender and weight.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility Criteria 1 - Recruitment Rate
Time Frame: Throughout study completion, an average of 2 years
|
The number of children, adolescents and young adults with a history of pediatric cancer who agree to participate compared to the total number approached for this study.
|
Throughout study completion, an average of 2 years
|
|
Feasibility Criteria 2 - Acceptance
Time Frame: Throughout study completion, an average of 2 years
|
Number of finished and discontinued exercise stress echocardiographies.
|
Throughout study completion, an average of 2 years
|
|
Feasibility Criteria 3 - Data Quality
Time Frame: Throughout study completion, an average of 2 years
|
Number of evaluable examination data.
|
Throughout study completion, an average of 2 years
|
|
Feasibility Criteria 4 - Practicability
Time Frame: Throughout study completion, an average of 2 years
|
Difference between scheduled and required time frame for the single examination.
|
Throughout study completion, an average of 2 years
|
|
Feasibility Criteria 5 - Participants' Feedback
Time Frame: Throughout study completion, an average of 2 years
|
Feedback questionnaire with multiple choice options and free text answers.
|
Throughout study completion, an average of 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reference Values of Healthy Peers
Time Frame: Throughout study completion, an average of 2 years
|
Assessment of reference values from age- and gender-matched healthy peers (matched pairs).
|
Throughout study completion, an average of 2 years
|
|
Analysis of Echocardiography Marker 1
Time Frame: During the procedure
|
Deformation Parameters in % (global longitudinal strain and circumferencial strain)
|
During the procedure
|
|
Analysis of Echocardiography Marker 2
Time Frame: During the procedure
|
Ejection Fraction (EF) in %
|
During the procedure
|
|
Analysis of Echocardiography Marker 3
Time Frame: During the procedure
|
M-Mode Parameter
|
During the procedure
|
|
Analysis of Echocardiography Marker 4
Time Frame: During the procedure
|
Tricuspid Annular Plane Systolic Excursion (TAPSE) in millimeter
|
During the procedure
|
|
Analysis of Echocardiography Marker 5
Time Frame: During the procedure
|
Left ventricle end diastolic volume (LVEDV) in ml/m²
|
During the procedure
|
|
Cardiorespiratory Fitness
Time Frame: During the procedure
|
Submaximal oxygen uptake VO2peak (ml/kg/min)
|
During the procedure
|
|
Physical Activity Level post-therapy
Time Frame: During the procedure
|
For participants with a history of pediatric cancer: Physical activity questionnaire ActiOn post-therapy for the assessment of the amount of moderate-to-vigorous physical activity.
|
During the procedure
|
|
Physical Activity Level in Healthy Control Subjects
Time Frame: During the procedure
|
For healthy control subjects: Physical activity questionnaire from the KiGGS study (German Health Interview and Examination Survey for Children and Adolescents).
|
During the procedure
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Renate Oberhoffer-Fritz, Prof. Dr. med., Institute of Preventive Pediatrics, Department of Sport and Health Sciences, TUM
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- German Heart Foundation
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Exercise stress echocardiography
-
China Medical University HospitalUnknownCardiovascular Diseases | STEMI | NSTEMITaiwan
-
Laval UniversityCanadian Institutes of Health Research (CIHR); University Hospital, Brest; Heart...RecruitingMitral Valve InsufficiencyCanada, Belgium, France
-
José OrtizInstituto de Salud Carlos IIICompletedMyocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Cardiac DeathSpain
-
London North West Healthcare NHS TrustCompletedCoronary Artery DiseaseUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e...RecruitingRight Ventricular DysfunctionItaly
-
University of Missouri-ColumbiaCompletedObesity | Metabolic Syndrome
-
Hospices Civils de LyonCompletedHereditary Hemorrhagic Telangiectasia | Rendu Osler DiseaseFrance
-
Medical University of ViennaUnknown
-
Centre Hospitalier Universitaire de NiceCompletedPulmonary HypertensionFrance